Cargando…

The requirement for the LysR-type regulator PtrA for Pseudomonas chlororaphis PA23 biocontrol revealed through proteomic and phenotypic analysis

BACKGROUND: Pseudomonas chlororaphis strain PA23 is a biocontrol agent capable of suppressing the fungal pathogen Sclerotinia sclerotiorum. This bacterium produces the antibiotics phenazine and pyrrolnitrin together with other metabolites believed to contribute to biocontrol. A mutant no longer capa...

Descripción completa

Detalles Bibliográficos
Autores principales: Klaponski, Natasha, Selin, Carrie, Duke, Kelly, Spicer, Vic, Fernando, Dilantha WG, Belmonte, Mark F, de Kievit, Teresa R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997438/
https://www.ncbi.nlm.nih.gov/pubmed/24739259
http://dx.doi.org/10.1186/1471-2180-14-94
_version_ 1782313193983442944
author Klaponski, Natasha
Selin, Carrie
Duke, Kelly
Spicer, Vic
Fernando, Dilantha WG
Belmonte, Mark F
de Kievit, Teresa R
author_facet Klaponski, Natasha
Selin, Carrie
Duke, Kelly
Spicer, Vic
Fernando, Dilantha WG
Belmonte, Mark F
de Kievit, Teresa R
author_sort Klaponski, Natasha
collection PubMed
description BACKGROUND: Pseudomonas chlororaphis strain PA23 is a biocontrol agent capable of suppressing the fungal pathogen Sclerotinia sclerotiorum. This bacterium produces the antibiotics phenazine and pyrrolnitrin together with other metabolites believed to contribute to biocontrol. A mutant no longer capable of inhibiting fungal growth was identified harboring a transposon insertion in a gene encoding a LysR-type transcriptional regulator (LTTR), designated ptrA (Pseudomonas transcriptional regulator). Isobaric tag for relative and absolute quantitation (iTRAQ) based protein analysis was used to reveal changes in protein expression patterns in the ptrA mutant compared to the PA23 wild type. RESULTS: Relative abundance profiles showed 59 differentially-expressed proteins in the ptrA mutant, which could be classified into 16 clusters of orthologous groups (COGs) based on their predicted functions. The largest COG category was the unknown function group, suggesting that many yet-to-be identified proteins are involved in the loss of fungal activity. In the secondary metabolite biosynthesis, transport and catabolism COG, seven proteins associated with phenazine biosynthesis and chitinase production were downregulated in the mutant. Phenotypic assays confirmed the loss of phenazines and chitinase activity. Upregulated proteins included a lipoprotein involved in iron transport, a flagellin and hook-associated protein and four proteins categorized into the translation, ribosome structure and biogenesis COG. Phenotypic analysis revealed that the mutant exhibited increased siderophore production and flagellar motility and an altered growth profile, supporting the proteomic findings. CONCLUSION: PtrA is a novel LTTR that is essential for PA23 fungal antagonism. Differential protein expression was observed across 16 COG categories suggesting PtrA is functioning as a global transcriptional regulator. Changes in protein expression were confirmed by phenotypic assays that showed reduced phenazine and chitinase expression, elevated flagellar motility and siderophore production, as well as early entrance into log phase growth.
format Online
Article
Text
id pubmed-3997438
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39974382014-04-24 The requirement for the LysR-type regulator PtrA for Pseudomonas chlororaphis PA23 biocontrol revealed through proteomic and phenotypic analysis Klaponski, Natasha Selin, Carrie Duke, Kelly Spicer, Vic Fernando, Dilantha WG Belmonte, Mark F de Kievit, Teresa R BMC Microbiol Research Article BACKGROUND: Pseudomonas chlororaphis strain PA23 is a biocontrol agent capable of suppressing the fungal pathogen Sclerotinia sclerotiorum. This bacterium produces the antibiotics phenazine and pyrrolnitrin together with other metabolites believed to contribute to biocontrol. A mutant no longer capable of inhibiting fungal growth was identified harboring a transposon insertion in a gene encoding a LysR-type transcriptional regulator (LTTR), designated ptrA (Pseudomonas transcriptional regulator). Isobaric tag for relative and absolute quantitation (iTRAQ) based protein analysis was used to reveal changes in protein expression patterns in the ptrA mutant compared to the PA23 wild type. RESULTS: Relative abundance profiles showed 59 differentially-expressed proteins in the ptrA mutant, which could be classified into 16 clusters of orthologous groups (COGs) based on their predicted functions. The largest COG category was the unknown function group, suggesting that many yet-to-be identified proteins are involved in the loss of fungal activity. In the secondary metabolite biosynthesis, transport and catabolism COG, seven proteins associated with phenazine biosynthesis and chitinase production were downregulated in the mutant. Phenotypic assays confirmed the loss of phenazines and chitinase activity. Upregulated proteins included a lipoprotein involved in iron transport, a flagellin and hook-associated protein and four proteins categorized into the translation, ribosome structure and biogenesis COG. Phenotypic analysis revealed that the mutant exhibited increased siderophore production and flagellar motility and an altered growth profile, supporting the proteomic findings. CONCLUSION: PtrA is a novel LTTR that is essential for PA23 fungal antagonism. Differential protein expression was observed across 16 COG categories suggesting PtrA is functioning as a global transcriptional regulator. Changes in protein expression were confirmed by phenotypic assays that showed reduced phenazine and chitinase expression, elevated flagellar motility and siderophore production, as well as early entrance into log phase growth. BioMed Central 2014-04-17 /pmc/articles/PMC3997438/ /pubmed/24739259 http://dx.doi.org/10.1186/1471-2180-14-94 Text en Copyright © 2014 Klaponski et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Klaponski, Natasha
Selin, Carrie
Duke, Kelly
Spicer, Vic
Fernando, Dilantha WG
Belmonte, Mark F
de Kievit, Teresa R
The requirement for the LysR-type regulator PtrA for Pseudomonas chlororaphis PA23 biocontrol revealed through proteomic and phenotypic analysis
title The requirement for the LysR-type regulator PtrA for Pseudomonas chlororaphis PA23 biocontrol revealed through proteomic and phenotypic analysis
title_full The requirement for the LysR-type regulator PtrA for Pseudomonas chlororaphis PA23 biocontrol revealed through proteomic and phenotypic analysis
title_fullStr The requirement for the LysR-type regulator PtrA for Pseudomonas chlororaphis PA23 biocontrol revealed through proteomic and phenotypic analysis
title_full_unstemmed The requirement for the LysR-type regulator PtrA for Pseudomonas chlororaphis PA23 biocontrol revealed through proteomic and phenotypic analysis
title_short The requirement for the LysR-type regulator PtrA for Pseudomonas chlororaphis PA23 biocontrol revealed through proteomic and phenotypic analysis
title_sort requirement for the lysr-type regulator ptra for pseudomonas chlororaphis pa23 biocontrol revealed through proteomic and phenotypic analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997438/
https://www.ncbi.nlm.nih.gov/pubmed/24739259
http://dx.doi.org/10.1186/1471-2180-14-94
work_keys_str_mv AT klaponskinatasha therequirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT selincarrie therequirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT dukekelly therequirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT spicervic therequirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT fernandodilanthawg therequirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT belmontemarkf therequirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT dekievitteresar therequirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT klaponskinatasha requirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT selincarrie requirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT dukekelly requirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT spicervic requirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT fernandodilanthawg requirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT belmontemarkf requirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis
AT dekievitteresar requirementforthelysrtyperegulatorptraforpseudomonaschlororaphispa23biocontrolrevealedthroughproteomicandphenotypicanalysis